UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

The Lancet (British edition), 2009-07, Vol.374 (9683), p.29-38

2009

Volltextzugriff (PDF)

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSOI)-IV substudy

Circulation (New York, N.Y.), 2003-07, Vol.108 (3), p.275-281

2003

Volltextzugriff (PDF)

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study

Respiratory research, 2016-04, Vol.17 (43), p.43-43, Article 43

2016

Volltextzugriff (PDF)

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study

Respiratory research, 2015-11, Vol.16 (142), p.142-142, Article 142

2015

Volltextzugriff (PDF)

The St. George’s Respiratory Questionnaire in Pulmonary Sarcoidosis

Lung, 2020-12, Vol.198 (6), p.917-924

2020

Volltextzugriff (PDF)

Phase 2a, randomized, double‐blind, placebo‐controlled, multicentre, parallel‐group study of an H4R‐antagonist (JNJ‐39758979) in adults with uncontrolled asthma

Clinical and experimental allergy, 2018-08, Vol.48 (8), p.957-969

2018

Volltextzugriff (PDF)

Endothelial cells in physiology and in the pathophysiology of vascular disorders

Blood, 1998-05, Vol.91 (10), p.3527-3561

1998

Volltextzugriff (PDF)

Sarcoidosis extent relates to molecular variability

Clinical and experimental immunology, 2017-06, Vol.188 (3), p.444-454

2017

Volltextzugriff (PDF)

Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma

Pulmonary pharmacology & therapeutics, 2014-10, Vol.29 (1), p.15-23

2014

Volltextzugriff (PDF)

Phase 2a, randomized, double-blind, placebo-controlled, multicentre, parallel-group study of an H 4 R-antagonist (JNJ-39758979) in adults with uncontrolled asthma

Clinical and experimental allergy, 2018-08, Vol.48 (8), p.957-969

2018

Volltextzugriff (PDF)

Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: One-year survival in the GUSTO IV-ACS (global use of strategies to open occluded coronary arteries IV: Acute coronary syndrome) trial

Circulation (New York, N.Y.), 2003-01, Vol.107 (3), p.437-442

2003

Volltextzugriff (PDF)

Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA

Gene therapy, 1999-06, Vol.6 (6), p.1092-1100

1999

Volltextzugriff (PDF)

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

European heart journal, 2004-09, Vol.25 (17), p.1494-1501

2004

Volltextzugriff (PDF)

C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis

Sarcoidosis, vasculitis, and diffuse lung diseases, 2010-07, Vol.27 (1), p.49-56

2010

Volltextzugriff (PDF)

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

Circulation (New York, N.Y.), 2001-07, Vol.104 (2), p.163-167

2001

Volltextzugriff (PDF)

Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysis

Journal of the American College of Cardiology, 1993-10, Vol.22 (4), p.1004-1009

1993

Volltextzugriff (PDF)

Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2

The Journal of biological chemistry, 1997-02, Vol.272 (7), p.4043-4049

1997

Volltextzugriff (PDF)

Anti-platelet factor 4/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes

Circulation (New York, N.Y.), 2003-05, Vol.107 (18), p.2307-2312

2003

Volltextzugriff (PDF)

Immunohistochemical localization of defensin in human coronary vessels

The American journal of pathology, 1997-03, Vol.150 (3), p.1009-1020

1997

Volltextzugriff (PDF)

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

The New England journal of medicine, 2008-05, Vol.358 (21), p.2205-2217

2008

Volltextzugriff (PDF)

High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (Thrombolysis In Myocardial Infarction) 14

Circulation (New York, N.Y.), 2000-06, Vol.101 (23), p.2690-2695

2000

Volltextzugriff (PDF)

Plasminogen activator system in human coronary atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 1995-09, Vol.15 (9), p.1432-1443

1995

Volltextzugriff (PDF)

Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion

Arteriosclerosis, thrombosis, and vascular biology, 1996-10, Vol.16 (10), p.1269-1276

1996

Volltextzugriff (PDF)

S.23. Expression Profiling of Skin and Peripheral Blood Mononuclear Cells from Patients with Cutaneous Sarcoidosis: An Interleukin-12 and Interferon Signature

Clinical immunology (Orlando, Fla.), 2009, Vol.131, p.S139-S140

2009

Volltextzugriff (PDF)

Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells

Arteriosclerosis, thrombosis, and vascular biology, 1998-05, Vol.18 (5), p.825-832

1998

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(146)

Publikationsform

Sprache

Englisch
(184)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSOI)-IV substudy

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study

The St. George’s Respiratory Questionnaire in Pulmonary Sarcoidosis

Phase 2a, randomized, double‐blind, placebo‐controlled, multicentre, parallel‐group study of an H4R‐antagonist (JNJ‐39758979) in adults with uncontrolled asthma

Endothelial cells in physiology and in the pathophysiology of vascular disorders

Sarcoidosis extent relates to molecular variability

Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma

Phase 2a, randomized, double-blind, placebo-controlled, multicentre, parallel-group study of an H 4 R-antagonist (JNJ-39758979) in adults with uncontrolled asthma

Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: One-year survival in the GUSTO IV-ACS (global use of strategies to open occluded coronary arteries IV: Acute coronary syndrome) trial

Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysis

Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2

Anti-platelet factor 4/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes

Immunohistochemical localization of defensin in human coronary vessels

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (Thrombolysis In Myocardial Infarction) 14

Plasminogen activator system in human coronary atherosclerosis

Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion

S.23. Expression Profiling of Skin and Peripheral Blood Mononuclear Cells from Patients with Cutaneous Sarcoidosis: An Interleukin-12 and Interferon Signature

Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells

Suchergebnisse filtern